Chlorisondamine (iodide) – 1 mg

Brand:
Cayman
CAS:
96750-66-2
Storage:
-20
UN-No:
De Minimis - 3077 / 9

Chlorisondamine is an antagonist of nicotinic acetylcholine receptors (nAChRs; IC50 = 1.8 µM in rat striatal synaptosomes) and a ganglion blocker.{38466} It decreases dopamine release induced by nicotine (Item Nos. 16535 | 20887) in a dose-dependent manner in rat striatal synaptosomes at concentrations ranging from 0-100 µM. The effect of chlorisondamine is long-lasting, with a 10 mg/kg dose blocking nicotine-induced stimulant activity for at least five weeks.{38463} Chlorisondamine (5 µg, i.c.v.) prevents rats from acquiring a (–)-nicotine-induced conditioned taste aversion response, a model of the aversive effects of nicotine.{38465} It also inhibits autonomic ganglia, providing approximately 50% inhibition of the contractile response in feline superior cervical ganglion nictitating membrane preparations when administered at a dose of 50 mg/kg.{38464}  

 

Available on backorder

SKU: 20119 - Category:

Description

A long-lasting antagonist of nAChRs (IC50 = 1.8 µM) and ganglion blocker; decreases nicotine-induced dopamine release in rat striatal synaptosomes at concentrations ranging from 0-100 µM; a dose of 10 mg/kg blocks nicotine-induced stimulant activity for at least five weeks; prevents acquisition of conditioned taste aversion in rats when used at a dose of 5 µg, i.c.v.; inhibits autonomic ganglia when used at a dose of 50 mg/kg in cats


Formal name: 4,5,6,7-tetrachloro-2,3-dihydro-2-methyl-2-[2-(trimethylammonio)ethyl]-1H-isoindolium, diiodide

Synonyms: 

Molecular weight: 611.9

CAS: 96750-66-2

Purity: ≥98%

Formulation: A crystalline solid


Product Type|Biochemicals|Ion Channel Modulation|Blockers||Research Area|Neuroscience|Behavioral Neuroscience|Addiction Research